Mesalamine-Induced Myocarditis and Coronary Vasculitis in a Pediatric Ulcerative Colitis Patient: A Case Report

• Auteurs principaux: Elimarys Perez-Colon (Auteur), Gul H. Dadlani (Auteur), Ivan Wilmot (Auteur), Michelle Miller (Auteur)
• Format: Livre
• Publié: Hindawi Limited, 2011-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Mesalamine-containing products are often a first-line treatment for ulcerative colitis. Severe adverse reactions to these products, including cardiovascular toxicity, are rarely seen in pediatric patients. We present a case of a 16-year-old boy with ulcerative colitis treated with Asacol, a mesalami...